MedTrace Logo

Comparing CCI and POSSUM for Predicting Oncogynecologic Surgery Complications

NCT07287280 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-12-17

No results posted yet for this study

Summary

With the global rates of gynecologic cancers on the rise, optimizing perioperative care is imperative. Accurate risk prediction is essential for enhancing patient care, directing preoperative interventions, and facilitating informed decision-making in oncology. This research compares two widely-used risk assessment tools: the Charlson Comorbidity Index (CCI) and the Physiological and Operative Severity Score for the enUmeration of Mortality and Morbidity (POSSUM), in predicting perioperative outcomes. The CCI predominantly addresses comorbidities, providing simplicity and broad applicability, while POSSUM incorporates both physiological and operative factors for a more comprehensive risk assessment. Despite their application across various surgical specialties, the specific utility of these tools in onco-gynecologic surgery remains insufficiently explored. The study aims to evaluate the effectiveness of CCI and POSSUM in predicting perioperative complications, with a focus on the incidence of these complications, length of hospital stay, and 30-day mortality. The implementation of these risk tools may enhance multidisciplinary risk management, thus improving patient outcomes in gynecologic oncology surgery.

Conditions

  • Gynecologic Surgical Procedures
  • Risk Assessment
  • Perioperative Care

Interventions

OTHER

CCI score

Charlson comorbidity index included age and medical conditions

OTHER

POSSUM score

POSSUM included physical status and laboratory investigation

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Patchareya Nivatpumin, M.D. · Department of Anesthesiology, Faculty of Medicine Siriraj Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2027-06-30
Completion
2027-10-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07287280 on ClinicalTrials.gov